Home Newsfeeds Needham Reiterates Buy on Coinbase Glb, Maintains $73 Price Target

Needham Reiterates Buy on Coinbase Glb, Maintains $73 Price Target

Needham analyst John Todaro reiterates Coinbase Glb (NASDAQ:COIN) with a Buy and maintains $73 price target.

byBenzinga Newsdesk

March 2, 2023

1 minute read

Needham analyst John Todaro reiterates Coinbase Glb (NASDAQ:COIN) with a Buy and maintains $73 price target.

Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

By Avi Kapoor

April 12, 8:04 AM

U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Friday.

APLD

Cathie Wood’s GM Novelty Wearing Off? Ark Sheds About One-Fourth Of Stake A Year After Taking A Fresh Position In Automaker

By Shanthi Rexaline

July 21, 1:47 AM

Cathie Wood’s Ark Invest on Thursday disposed off a chunk of shares of legacy automaker General Motors Corp.…

ARKQ

Tesla, Amazon, Apple, Aurinia Pharma, Vera Therapeutics: Why These 5 Stocks Are Drawing Investors’ Attention Today

By Bhavik Nair

January 3, 9:09 PM

Major Wall Street indices closed in the red on Tuesday, the first trading day of 2023, as concerns over rising rates and inflation still seem to drive investor sentiments.

AAPL

Why Fear Level Among US Investors Is Increasing

By Lisa Levin

December 21, 4:19 AM

The CNN Money Fear and Greed index showed a slight increase in the fear level among US investors. US stocks closed slightly higher on Tuesday, following a surprise move by the Bank of Japan to widen its yield cap on its long-term bonds.

CCL

Needham Reiterates Buy on Coinbase Glb, Maintains $73 Price Target

Related Posts

Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

Cathie Wood’s GM Novelty Wearing Off? Ark Sheds About One-Fourth Of Stake A Year After Taking A Fresh Position In Automaker

Tesla, Amazon, Apple, Aurinia Pharma, Vera Therapeutics: Why These 5 Stocks Are Drawing Investors’ Attention Today

Why Fear Level Among US Investors Is Increasing